WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹31 Cr | ₹56 Cr | ₹-10 Cr | ₹81 Cr | ₹-13 Cr |
What is the latest Consolidated Net Profit of WANBURY ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹-10 Cr |
| Mar2022 | ₹81 Cr |
| Mar2021 | ₹-13 Cr |
How is Consolidated Net Profit of WANBURY Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | -45.44 | |
| Mar2024 | ₹56 Cr | Positive | |
| Mar2023 | ₹-10 Cr | Negative | |
| Mar2022 | ₹81 Cr | Positive | |
| Mar2021 | ₹-13 Cr | - | |
Compare Consolidated Net Profit of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹631.9 Cr | 1.2% | -18.7% | -24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 1.2% |
-18.7% |
-24.7% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses